TransCode Therapeutics, Inc. (RNAZ) — Analyst estimates
Consensus analyst estimates for TransCode Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 500K | -8.96 | 1 |
| 2027 | 9.70M | -6.72 | 1 |
| 2028 | 9.90M | -5.6 | 1 |
| 2029 | 27.80M | -5.04 | 1 |
Consensus analyst estimates by fiscal year.